Victory Capital Management Inc Syros Pharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

  • $95.8 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 07, 2020
SELL
$5.21 - $11.03 $20,298 - $42,972
-3,896 Closed
0 $0
Q1 2020

May 04, 2020
SELL
$4.46 - $9.2 $1,065 - $2,198
-239 Reduced 5.78%
3,896 $23,000
Q4 2019

Feb 04, 2020
SELL
$4.52 - $10.1 $3,069 - $6,857
-679 Reduced 14.1%
4,135 $29,000
Q3 2019

Nov 12, 2019
BUY
$7.14 - $11.65 $34,371 - $56,083
4,814 New
4,814 $50,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email